Ovarian germ cell tumor laboratory tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{Sahar}} {{MD}} | {{CMG}}; {{AE}} {{Sahar}} {{MD}} | ||
==Overview== | ==Overview== | ||
An elevated concentration [[Alpha-fetoprotein|a-fetoprotein]] ([[Alpha-fetoprotein|AFP]]) and [[Human chorionic gonadotrophin|b-human chorionic gonadotrophin]] (b-hCG) are diagnostic of malignant ovarian germ cell tumors. | |||
|- | |||
|- | |||
==Ovarian germ cell tumor Laboratory Findings== | ==Ovarian germ cell tumor Laboratory Findings== | ||
| Line 60: | Line 36: | ||
===Mature teratoma=== | ===Mature teratoma=== | ||
* [[Mature cystic teratoma|Mature teratoma]] is associated with increased level of [[CA 19-9]]. <ref name="Yayla AbideBostancı Ergen2018">{{cite journal|last1=Yayla Abide|first1=Çiğdem|last2=Bostancı Ergen|first2=Evrim|title=Retrospective analysis of mature cystic teratomas in a single center and review of the literature|journal=Journal of Turkish Society of Obstetric and Gynecology|volume=15|issue=2|year=2018|pages=95–98|issn=1307699X|doi=10.4274/tjod.86244}}</ref> | * [[Mature cystic teratoma|Mature teratoma]] is associated with increased level of [[CA 19-9]]. <ref name="Yayla AbideBostancı Ergen2018">{{cite journal|last1=Yayla Abide|first1=Çiğdem|last2=Bostancı Ergen|first2=Evrim|title=Retrospective analysis of mature cystic teratomas in a single center and review of the literature|journal=Journal of Turkish Society of Obstetric and Gynecology|volume=15|issue=2|year=2018|pages=95–98|issn=1307699X|doi=10.4274/tjod.86244}}</ref> | ||
* There is a report suggesting a role for increased levels of [[CA-125]] | * There is a report suggesting a role for increased levels of [[CA-125]] and [[AFP]] [[tumor markers]] in differentiating the immature [[teratoma]] and [[Mature cystic teratoma|mature teratoma]].<ref name="pmid18184473">{{cite journal |vauthors=Chen C, Li JD, Huang H, Feng YL, Wang LH, Chen L |title=[Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary] |language=Chinese |journal=Ai Zheng |volume=27 |issue=1 |pages=92–5 |date=January 2008 |pmid=18184473 |doi= |url=}}</ref> | ||
===Immature teratoma=== | ===Immature teratoma=== | ||
* Immature [[teratoma]] is associated with elevated [[AFP]] in one third of the cases.<ref name="Gershenson2007">{{cite journal|last1=Gershenson|first1=David M.|title=Management of Ovarian Germ Cell Tumors|journal=Journal of Clinical Oncology|volume=25|issue=20|year=2007|pages=2938–2943|issn=0732-183X|doi=10.1200/JCO.2007.10.8738}}</ref> | * Immature [[teratoma]] is associated with elevated [[AFP]] in one third of the cases.<ref name="Gershenson2007">{{cite journal|last1=Gershenson|first1=David M.|title=Management of Ovarian Germ Cell Tumors|journal=Journal of Clinical Oncology|volume=25|issue=20|year=2007|pages=2938–2943|issn=0732-183X|doi=10.1200/JCO.2007.10.8738}}</ref> | ||
| Line 68: | Line 45: | ||
*[[LDH]] and [[Alkaline phosphatase|ALK-P]] may be elevated nonspecifically. | *[[LDH]] and [[Alkaline phosphatase|ALK-P]] may be elevated nonspecifically. | ||
===Embryonal carcinoma=== | ===Embryonal carcinoma=== | ||
*They are capable of producing [[alpha-fetoprotein]] or [[human chorionic gonadotropin]].<ref name=" | *They are capable of producing [[alpha-fetoprotein]] or [[human chorionic gonadotropin]].<ref name="pmid12733128">{{cite journal |vauthors=Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN |title=Pathology and classification of ovarian tumors |journal=Cancer |volume=97 |issue=10 Suppl |pages=2631–42 |date=May 2003 |pmid=12733128 |doi=10.1002/cncr.11345 |url=}}</ref> | ||
===Endodermal sinus tumor=== | ===Endodermal sinus tumor=== | ||
* [[Yolk sac tumor]] is associated with increased level of [[Alpha-fetoprotein|AFP]].<ref name="SteinWasnik2017">{{cite journal|last1=Stein|first1=Erica B.|last2=Wasnik|first2=Ashish P.|last3=Sciallis|first3=Andrew P.|last4=Kamaya|first4=Aya|last5=Maturen|first5=Katherine E.|title=MR Imaging–Pathologic Correlation in Ovarian Cancer|journal=Magnetic Resonance Imaging Clinics of North America|volume=25|issue=3|year=2017|pages=545–562|issn=10649689|doi=10.1016/j.mric.2017.03.004}}</ref> | * [[Yolk sac tumor]] is associated with increased level of [[Alpha-fetoprotein|AFP]].<ref name="SteinWasnik2017">{{cite journal|last1=Stein|first1=Erica B.|last2=Wasnik|first2=Ashish P.|last3=Sciallis|first3=Andrew P.|last4=Kamaya|first4=Aya|last5=Maturen|first5=Katherine E.|title=MR Imaging–Pathologic Correlation in Ovarian Cancer|journal=Magnetic Resonance Imaging Clinics of North America|volume=25|issue=3|year=2017|pages=545–562|issn=10649689|doi=10.1016/j.mric.2017.03.004}}</ref> | ||
| Line 74: | Line 52: | ||
*These [[tumors]] may be associated with elevated levels of b-[[Human chorionic gonadotropin|hCG]] and [[AFP]].<ref name="LowIlancheran2012">{{cite journal|last1=Low|first1=Jeffrey J.H.|last2=Ilancheran|first2=Arunachalam|last3=Ng|first3=Joseph S.|title=Malignant ovarian germ-cell tumours|journal=Best Practice & Research Clinical Obstetrics & Gynaecology|volume=26|issue=3|year=2012|pages=347–355|issn=15216934|doi=10.1016/j.bpobgyn.2012.01.002}}</ref> | *These [[tumors]] may be associated with elevated levels of b-[[Human chorionic gonadotropin|hCG]] and [[AFP]].<ref name="LowIlancheran2012">{{cite journal|last1=Low|first1=Jeffrey J.H.|last2=Ilancheran|first2=Arunachalam|last3=Ng|first3=Joseph S.|title=Malignant ovarian germ-cell tumours|journal=Best Practice & Research Clinical Obstetrics & Gynaecology|volume=26|issue=3|year=2012|pages=347–355|issn=15216934|doi=10.1016/j.bpobgyn.2012.01.002}}</ref> | ||
===Non-gestational choriocarcinoma=== | ===Non-gestational choriocarcinoma=== | ||
*They can produce [[human chorionic gonadotropin]].<ref name=" | *They can produce [[human chorionic gonadotropin]].<ref name="pmid12733128">{{cite journal |vauthors=Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN |title=Pathology and classification of ovarian tumors |journal=Cancer |volume=97 |issue=10 Suppl |pages=2631–42 |date=May 2003 |pmid=12733128 |doi=10.1002/cncr.11345 |url=}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 04:42, 15 April 2019
|
Ovarian germ cell tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian germ cell tumor laboratory tests On the Web |
|
American Roentgen Ray Society Images of Ovarian germ cell tumor laboratory tests |
|
Risk calculators and risk factors for Ovarian germ cell tumor laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Monalisa Dmello, M.B,B.S., M.D. [3]
Overview
An elevated concentration a-fetoprotein (AFP) and b-human chorionic gonadotrophin (b-hCG) are diagnostic of malignant ovarian germ cell tumors.
Ovarian germ cell tumor Laboratory Findings
An elevated concentration a-fetoprotein (AFP) and b-human chorionic gonadotrophin (b-hCG) are diagnostic of malignant ovarian germ cell tumors.[1]
The tumor marker associated with ovarian germ cell tumor subtypes are as follows:[2]
| Ovarian germ cell tumor subtype | Tumor markers expressed |
| Dysgerminoma | |
| Embryonal carcinoma | |
| Endodermal sinus tumor or yolk sac tumors | |
| Polyembryoma | |
| Teratoma |
|
| Choriocarcinoma |
Mature teratoma
- Mature teratoma is associated with increased level of CA 19-9. [3]
- There is a report suggesting a role for increased levels of CA-125 and AFP tumor markers in differentiating the immature teratoma and mature teratoma.[4]
Immature teratoma
Dysgerminoma
- Pure dysgerminoma, usually secret no hormones. However, 5% of tumors are capable of producing B-hCG.[6]
- Multinucleated syncytiotrophoblastic giant cells, in the dysgerminoma, produce B-hCG.
- LDH and ALK-P may be elevated nonspecifically.
Embryonal carcinoma
- They are capable of producing alpha-fetoprotein or human chorionic gonadotropin.[7]
Endodermal sinus tumor
- Yolk sac tumor is associated with increased level of AFP.[8]
Polyembryoma
Non-gestational choriocarcinoma
- They can produce human chorionic gonadotropin.[7]
References
- ↑ Pectasides, D.; Pectasides, E.; Kassanos, D. (2008). "Germ cell tumors of the ovary". Cancer Treatment Reviews. 34 (5): 427–441. doi:10.1016/j.ctrv.2008.02.002. ISSN 0305-7372.
- ↑ Ovary: Germ cell tumors. http://atlasgeneticsoncology.org/Tumors/OvarianGermCellID5067.html. URL Accessed on November 10, 2015
- ↑ Yayla Abide, Çiğdem; Bostancı Ergen, Evrim (2018). "Retrospective analysis of mature cystic teratomas in a single center and review of the literature". Journal of Turkish Society of Obstetric and Gynecology. 15 (2): 95–98. doi:10.4274/tjod.86244. ISSN 1307-699X.
- ↑ Chen C, Li JD, Huang H, Feng YL, Wang LH, Chen L (January 2008). "[Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary]". Ai Zheng (in Chinese). 27 (1): 92–5. PMID 18184473.
- ↑ Gershenson, David M. (2007). "Management of Ovarian Germ Cell Tumors". Journal of Clinical Oncology. 25 (20): 2938–2943. doi:10.1200/JCO.2007.10.8738. ISSN 0732-183X.
- ↑ Shaaban, Akram M.; Rezvani, Maryam; Elsayes, Khaled M.; Baskin, Henry; Mourad, Amr; Foster, Bryan R.; Jarboe, Elke A.; Menias, Christine O. (2014). "Ovarian Malignant Germ Cell Tumors: Cellular Classification and Clinical and Imaging Features". RadioGraphics. 34 (3): 777–801. doi:10.1148/rg.343130067. ISSN 0271-5333.
- ↑ 7.0 7.1 Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN (May 2003). "Pathology and classification of ovarian tumors". Cancer. 97 (10 Suppl): 2631–42. doi:10.1002/cncr.11345. PMID 12733128.
- ↑ Stein, Erica B.; Wasnik, Ashish P.; Sciallis, Andrew P.; Kamaya, Aya; Maturen, Katherine E. (2017). "MR Imaging–Pathologic Correlation in Ovarian Cancer". Magnetic Resonance Imaging Clinics of North America. 25 (3): 545–562. doi:10.1016/j.mric.2017.03.004. ISSN 1064-9689.
- ↑ Low, Jeffrey J.H.; Ilancheran, Arunachalam; Ng, Joseph S. (2012). "Malignant ovarian germ-cell tumours". Best Practice & Research Clinical Obstetrics & Gynaecology. 26 (3): 347–355. doi:10.1016/j.bpobgyn.2012.01.002. ISSN 1521-6934.